Turkiye Teknoloji Gelistirme Vakfi
VC Fund
Ankara, Turkey
Turkiye Teknoloji Gelistirme Vakfi is a VC fund in Ankara focused on Software and Health Care. Having supported Research and Development and Technological Innovation projects in the private sector since 1991, the Technology Development Foundation of Turkey (TTGV) has proven to be a successful example to all of Europe as an innovative and dynamic intermediary. Intermediaries were mentioned in the EU Lisbon Communiqué as being necessary forconveying public support for R&D in the private sector. As one of the providers of one of the many bridges felt every passing day between the legislation in line with the national goals of the public and private sector, the TTGV helps maintain the existence of a transparent, observable and effective mechanism that provides opportunities for participation in the private sector through the management of public funds. Soft loans and compulsory company contributions, which make up the main principles behind TTGV’s support, have provided important benefits to Turkey’s R&D capacity thus far through the “multiplier effect” by promoting an increased contribution of public funds to R&D expenses in the private sector. TTGV is evaluating the expectations, needs and priorities of the private sector and the public, by developing new support mechanisms suited towards the changing conditions and circumstances of Turkey. TTGV employs those mechanisms. Today, TTGV is a sought out partner, both inside and outside of Turkey, in the field of technological innovation.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Turkiye Teknoloji Gelistirme Vakfi invests in
Stages Turkiye Teknoloji Gelistirme Vakfi invests in
Countries Turkiye Teknoloji Gelistirme Vakfi invests in
Round sizes
Round size
- Seed
- $1.8M–$2.4M
Investment Focus
Industry
- Software 2 (22%)
- Health Care 2 (22%)
- Health Diagnostics 2 (22%)
- SaaS 1 (11%)
- Google 1 (11%)
Stage
- Seed 3 (33%)
- Grant 1 (11%)
- Pre-Seed 1 (11%)
- Series A 1 (11%)
- Series B 1 (11%)
Country
- Turkey 6 (67%)
- United States 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Mindsite enables eCommerce professionals to boost their online sales by tracking and analyzing eCommerce fundamentals such as product availability, price&promo strategy, product content and brand visibility. | $2M / Jan 14, 2026 | ||
| Thread in Motion is an IIoT company that develops a wearable technology platform designed to increase operational efficiency in production and logistics facilities. They digitize workers with wearable technology products and provide machine-human interaction with IoT devices also create and analyze them with their software platform. | $750K / Convertible Note / Sep 29, 2023 | ||
| Fazla Gıda is a technology solutions company that prevents food waste. | $6M / Series B / Jun 07, 2023 | ||
| Wask is a digital marketing software. All digital advertisers can manage and report a Ad accounts, Its İntegratable with Facebook & Instagram Ads, Google Ads, Twitter Ads and Linkedin Ads. | $2.4M / Seed / Mar 28, 2023 | ||
| Mindsite enables eCommerce professionals to boost their online sales by tracking and analyzing eCommerce fundamentals such as product availability, price&promo strategy, product content and brand visibility. | $1.9M / Seed / Dec 29, 2022 | ||
| Hipporello is a no-code power-up building platform for Trello. It comes with a visual no code power-up builder for unique processes. Users can either build a power-up from scratch for their custom needs or they can use any of ready to use power-ups like Service Desk, Applicant Tracking System, Status Page, Blog, etc. Users can centralize manybusiness processes in Trello by adding multiple power-ups into their Hipporello Workspace where they can manage people, web pages, tasks, contacts and requests. | $1.8M / Seed / Dec 01, 2022 | ||
| 50% of people with chronic diseases do not take medications as prescribed. Improper medication use, especially for elderly patients, leads to hospitalizations and costs insurers billions of dollars. Current apps in the market are too complicated and difficult to use for the elderly who suffer the most from chronic diseases. Albert is a voice-basedhealth assistant which is accessible through mobile app, Amazon Alexa and Google assistant. Our machine learning algorithms create a unique conversational medication management experience. Elderly patients don’t have to text anymore. They will talk with Albert to manage their medications in an easy and effortless way. Patients can easily track health measurements, keep medical diary and set pill reminder by voice command. Furthermore, “Caregiver Mode” allows family members to manage and monitor their relatives’ treatment remotely. Albert helps elderly patients to take the right dose at the right time and help insurers to have less medical expenses, more satisfied customers. | $87K / Grant / May 18, 2021 | ||
| EyeCheckup is an early diagnosis software for preventing blindness and vision loss. Everyone can check their eyes at any Primary Care site (family doctor, hospital) for FREE! AI based retina diagnosis and follow-up are covered by health insurance! | $150K / Pre-Seed / Jan 01, 2021 | ||
| See all 9 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Turkiye Teknoloji Gelistirme Vakfi invest in?
Turkiye Teknoloji Gelistirme Vakfi invests primarily in Software, Health Care and Health Diagnostics startups, most often at Seed and Grant stage. Most of the 9 investments tracked by Shizune back companies in Turkey. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Turkiye Teknoloji Gelistirme Vakfi's check size?
Turkiye Teknoloji Gelistirme Vakfi typically joins rounds of $1.8M–$2.4M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Turkiye Teknoloji Gelistirme Vakfi participates in.
When did Turkiye Teknoloji Gelistirme Vakfi last invest?
The most recent investment recorded for Turkiye Teknoloji Gelistirme Vakfi closed in Jan 2026. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
